Test Price
2,800 AED✅ Home Collection Available
GCK Gene MODY Type 2 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Gold‑Standard MODY2 Genetic Confirmation
This Next‑Generation Sequencing test screens the entire GCK gene to diagnose Maturity‑Onset Diabetes of the Young type 2 with 99.9% diagnostic sensitivity.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM – 11 PM.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance included with a DHA‑licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The GCK MODY2 NGS test analyses glucokinase gene variants to differentiate a generally mild, non‑progressive hyperglycaemia from aggressive diabetes forms. A positive result often prevents unnecessary insulin or oral hypoglycaemic therapy.
| Feature | Our Test (MODY2 NGS) | Closest Alternative (Basic Diabetes Genetic Panel) |
|---|---|---|
| Precision | Full GCK gene sequencing, 99.9% sensitivity | Targeted hotspot analysis, may miss rare mutations |
| Method | Next‑Generation Sequencing (NGS) with Sanger confirmation | PCR‑based genotyping or limited sequencing |
| Turnaround Time | 3–4 Weeks | Varies (often 6–8 weeks) |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I understand that genetic testing can feel overwhelming. This MODY2 analysis provides clarity, distinguishing a generally mild hyperglycaemia from more aggressive diabetes forms. Always interpret results alongside clinical presentation and family history. You are not alone—our team guides you through every result.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not alter any prescribed diabetes treatment without consulting your treating physician. Genetic results inform long‑term management but do not replace immediate clinical decisions. Always discuss medication changes with your healthcare provider.
Exclusion Criteria & Emergency Red Flags
- Testing is not advised during an acute metabolic crisis (e.g., diabetic ketoacidosis, hyperosmolar hyperglycaemic state) – stabilise first.
- For minors (under 18), consent from legal guardian(s) is mandatory under UAE Federal Law.
- If you experience sudden severe hyperglycaemia, confusion, or rapid weight loss, seek emergency medical care immediately. This test is a diagnostic tool, not an emergency intervention.
- Pregnancy: Additional genetic counselling should be sought; test can be performed on maternal blood with extra clinical correlation.
Patient FAQ & Clinical Guidance
1. What is the GCK MODY2 test and how can it change my diabetes treatment?
The GCK MODY2 NGS test analyses the glucokinase gene to diagnose maturity‑onset diabetes of the young type 2 with 99.9% accuracy, guiding personalised treatment. Because MODY2 is typically mild and non‑progressive, a positive result often means you can safely stop unnecessary medications—but always under your doctor’s supervision.
2. What samples are accepted and how do I prepare?
You can provide a standard blood draw (EDTA), extracted DNA, or a simple finger‑prick drop on an FTA card—no fasting required. Before testing, a mandatory genetic counselling session (included) will help draw your family pedigree and explain implications. We offer home collection 8 AM – 11 PM.
3. Is this covered by UAE insurance and how long do results take?
Results are ready in 3–4 weeks, and we verify direct billing with your insurer via WhatsApp at +971 54 548 8731 before collection. We comply with UAE PDPL for data privacy. Your genetic data is never shared without explicit consent.
UAE Regulatory & Data Privacy Adherence
Data Protection: Your genetic information is processed in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Clinical Safety & Consent: All procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring informed consent and patient safety throughout the testing journey.
DNA Labs UAE is licensed by the Dubai Health Authority (DHA) under facility license number 1143. Your trust and privacy are our highest priority.
Clinical & Logistical Metadata
| Test Name | GCK Gene MODY Type 2 Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA), extracted DNA, or FTA card – VIP Mobile Phlebotomy & Cold-Chain Home Collection available daily 8 AM – 11 PM. |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | E11.8 (Diabetes mellitus due to genetic defect of beta-cell function) |
| LOINC Code | 92815-3 (GCK gene variant detection in blood by NGS) |
| DHA Facility License & Address | License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians